5-(4-Boc-piperazino)-2-nitroanisole
98%
- Product Code: 86186
CAS:
1017782-79-4
| Molecular Weight: | 337.37 g./mol | Molecular Formula: | C₁₆H₂₃N₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09972251 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This chemical is primarily utilized in organic synthesis as an intermediate for the preparation of more complex molecules. It is often employed in pharmaceutical research, particularly in the development of compounds with potential therapeutic applications. The Boc (tert-butoxycarbonyl) protecting group on the piperazine moiety allows for selective reactions to be carried out on other parts of the molecule, making it valuable in multi-step synthetic processes. Additionally, the nitro and methoxy groups provide reactive sites for further functionalization, enabling the creation of diverse chemical structures. Its role in medicinal chemistry includes the synthesis of drug candidates targeting various biological pathways, such as central nervous system disorders or infectious diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | £121.93 |
+
-
|
| 5.000 | 10-20 days | £370.47 |
+
-
|
5-(4-Boc-piperazino)-2-nitroanisole
This chemical is primarily utilized in organic synthesis as an intermediate for the preparation of more complex molecules. It is often employed in pharmaceutical research, particularly in the development of compounds with potential therapeutic applications. The Boc (tert-butoxycarbonyl) protecting group on the piperazine moiety allows for selective reactions to be carried out on other parts of the molecule, making it valuable in multi-step synthetic processes. Additionally, the nitro and methoxy groups provide reactive sites for further functionalization, enabling the creation of diverse chemical structures. Its role in medicinal chemistry includes the synthesis of drug candidates targeting various biological pathways, such as central nervous system disorders or infectious diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :